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DenmarkIn the current issue of European Journal of Vascular and
Endovascular Surgery, Svensjö et al. report a Markov model-
based study on the cost-effectiveness of population
screening for abdominal aortic aneurysm (AAA) versus no
screening.1 The study replicates previous ﬁndings for the
Swedish context2 by concluding that screening is cost-
effective at conventional thresholds for willingness to pay
for additional quality-adjusted life years. It is also in
consensus with the conclusions of quite a few other inter-
national cost effectiveness models from, for example the
UK, Denmark, The Netherlands, Norway, and Italy.
The reader might therefore ask why another model is
motivated? The authors rightfully argue that the epidemi-
ology has changed in recent years as the endovascular
repair technique has evolved, the prevalence declines, and
incidental detection rates increase, so the cost-effectiveness
therefore has to be reassessed. In this light, the most
interesting result of the study perhaps is the breakeven
points at which decreasing prevalence or increasing rates of
incidental detection lead screening to become cost-inef-
fective; these were estimated at <0.5% and >75%,
respectively. Although variation in prevalence and incidental
detection has been observed across different studies, these
estimates underline the robustness of the ﬁnding that
population screening for AAA is cost-effective, as few
commentators ﬁnd such low prevalence and such high
incidental detection likely to be the case in the near future.
However, the methodology of the study follows the tradi-
tion of many previous models but is simpliﬁed in terms of
model structure and the fact that no probabilistic sensitivity
analysis is conducted, although this is recommended in
good practice guidelines. The simpliﬁed model structure
does not discriminate between small and large aneurysms,
which essentially mean that ﬁndings are based on an
assumption of constant growth and rupture risk of aneu-
rysms. The lack of probabilistic sensitivity analysis can be
thought of as a parallel to a lack of conﬁdence intervals for
the main result. In addition, the current model is partlyDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.12.023
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http://dx.doi.org/10.1016/j.ejvs.2013.12.024based on old data from the MASS trial where the propor-
tion of ruptures reaching surgery is only about half of what
is reported in recent Danish estimates3 and where rupture
risks are negatively associated with calendar years.4
Long-term follow-up of previous screening trials such as
the MASS now show ruptures in the screening arms, which
indicates that aneurysms that were below the clinical
threshold at the time of screening have grown. This poses a
new research question of whether to rescreen after some
years. Policywise this would be a natural next step in
healthcare systems where one-time screening is already
implemented, such as in the UK and Sweden. We recently
assessed the cost-effectiveness of rescreening for a modern
Danish context and found it to be likely to be also cost-
effective.5 It would be very interesting and policy-relevant
to see if that would also be the case in Sweden.REFERENCES
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